Journal ArticleOPEN ACCESS

P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content

  • Soumyanath A
  • Denne T
  • Peterson A
  • et al.
BMC Complementary and Alternative Medicine (2012) 12(S1)
DOI: 10.1186/1472-6882-12-s1-p36
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

… Mucuna pruriens (mucuna) seeds contain 3-6% L-DOPA, and have been used in traditional Ayurvedic medicine to treat diseases resembling Parkinson’s disease (PD). Pilot studies in …

Cite

CITATION STYLE

APA

Soumyanath, A., Denne, T., Peterson, A., & Shinto, L. (2012). P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content. BMC Complementary and Alternative Medicine, 12(S1). https://doi.org/10.1186/1472-6882-12-s1-p36

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free